Rankings
▼
Calendar
RGEN Q2 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q2 2018 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$48M
+47.1% YoY
Gross Profit
$27M
55.8% margin
Operating Income
$4M
9.0% margin
Net Income
$3M
5.7% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
+6.5%
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$3M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$745M
Total Liabilities
$146M
Stockholders' Equity
$599M
Cash & Equivalents
$176M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$48M
$32M
+47.1%
Gross Profit
$27M
$19M
+43.9%
Operating Income
$4M
$5M
-21.9%
Net Income
$3M
$8M
-67.6%
Revenue Segments
Product
$48M
100%
Geographic Segments
North America
$22M
47%
Europe
$20M
41%
Asia and Australia
$6M
12%
All Other
$55,000
0%
← FY 2018
All Quarters
Q3 2018 →